Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment-Reference-Cited by-同舟云学术

Influence of cytarabine metabolic pathway polymorphisms in acute myeloid leukemia induction treatment

Published:2017-06-02 Issue:12 Volume:58 Page:2880-2894
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Megías-Vericat Juan Eduardo¹²,Montesinos Pau³,Herrero María José¹⁴,Moscardó Federico³,Bosó Virginia¹²,Martínez-Cuadrón David³,Rojas Luis¹⁵,Rodríguez-Veiga Rebeca³,Boluda Blanca³,Sendra Luis¹⁴,Cervera José³,Poveda José Luis²,Sanz Miguel Ángel³,Aliño Salvador F.¹⁴⁶

Affiliation:

1. Unidad de Farmacogenética, Instituto Investigación Sanitaria La Fe and Área del Medicamento, Hospital Universitario y Politécnico La Fe., Valencia, Spain;

2. Servicio de Farmacia, Área del Medicamento, Hospital Universitario y Politécnico La Fe Avda, Valencia, Spain;

3. Servicio de Hematología y Hemoterapia, Hospital Universitario y Politécnico La Fe, Avda, Valencia, Spain;

4. Departamento Farmacología, Facultad de Medicina, Universidad de Valencia. Avda., Valencia, Spain;

5. Department of Internal Medicine, Faculty of Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile;

6. Unidad de Farmacología Clínica, Área del Medicamento, Hospital Universitario y Politécnico La Fe. Avda, Valencia, Spain

Funder

Instituto Carlos III

Instituto Investigación Sanitaria La Fe

Cooperative Research Thematic Network

Publisher

Informa UK Limited

Subject

Cancer Research,Oncology,Hematology

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2017.1323267

Reference47 articles.

1. Pharmacogenomics and the treatment of acute myeloid leukemia

2. Combined interaction of multi-locus genetic polymorphisms in cytarabine arabinoside metabolic pathway on clinical outcomes in adult acute myeloid leukaemia (AML) patients

3. SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study

4. Association between single nucleotide polymorphisms in deoxycytidine kinase and treatment response among acute myeloid leukaemia patients

Cited by 14 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Germline SNPs previously implicated as prognostic biomarkers do not associate with outcomes in intensively treated AML;Blood Advances;2023-03-20

2. Pharmacogenetics of ABCB1 , CDA , DCK , GSTT1 , GSTM1 and outcomes in a cohort of pediatric acute myeloid leukemia patients from Colombia;Cancer Reports;2022-10-31

3. 5′‐nucleotidase, cytosolic II genotype, and clinical outcome in patients with acute myeloid leukemia with intermediate‐risk cytogenetics;European Journal of Haematology;2022-09-16

4. The Prognostic Significance of Genetic Polymorphisms of Deoxycytidine Kinase and Cytidine Deaminase on the outcome of Adult Acute Myeloid Leukemia Patients with Cytarabine Based Chemotherapy;International Journal of Hematology and Oncology;2022-04-30

5. Role of Pharmacogenetics in the Treatment of Acute Myeloid Leukemia: Systematic Review and Future Perspectives;Pharmaceutics;2022-03-03